Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West Africa

Archive ouverte

Jaspard, Marie | Sow, Mamadou Saliou | Juchet, Sylvain | Diendere, Eric | Serra, Beatrice | Kojan, Richard | Sivahera, Billy | Martin, Caroline | Kinda, Moumouni | Lang, Hans-Joerg | Bangaly Sako, Fode | Amara Traore, Fode | Koumbem, Eudoxie | Tinto, Halidou | Sanou, Adama | Sondo, Apoline | Kabore, Flavien | Donamou, Joseph | Guilavogui, Jean-Paul-Yassa | Velardo, Fanny | Bicaba, Brice | Marcy, Olivier | Augier, Augustin | Sayadi, Sani | Poda, Armel | Keita, Sakoba | Anglaret, Xavier | Malvy, Denis

Edité par CCSD ; Elsevier -

International audience. OBJECTIVES: The overall death toll from COVID-19 in Africa is reported to be low but there is little individual-level evidence on the severity of the disease. This study examined the clinical spectrum and outcome of patients monitored in COVID-19 care centres (CCCs) in two West-African countries. METHODS: Burkina Faso and Guinea set up referral CCCs to hospitalise all symptomatic SARS-CoV-2 carriers, regardless of the severity of their symptoms. Data collected from hospitalised patients by November 2020 are presented. RESULT: A total of 1,805 patients (64% men, median age 41 years) were admitted with COVID-19. Symptoms lasted for a median of 7 days (IQR 4-11). During hospitalisation, 443 (25%) had a SpO2 < 94% at least once, 237 (13%) received oxygen and 266 (15%) took corticosteroids. Mortality was 5% overall, and 1%, 5% and 14% in patients aged <40, 40-59 and ≥60 years, respectively. In multivariable analysis, the risk of death was higher in men (aOR 2.0, 95% CI 1.1; 3.6), people aged ≥60 years (aOR 2.9, 95% CI 1.7; 4.8) and those with chronic hypertension (aOR 2.1, 95% CI 1.2; 3.4). CONCLUSION: COVID-19 is as severe in Africa as elsewhere, and there must be more vigilance for common risk factors such as older age and hypertension.

Suggestions

Du même auteur

Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo

Archive ouverte | Jaspard, Marie | CCSD

International audience. BACKGROUND: As mortality remains high for patients with Ebola virus disease (EVD) despite new treatment options, the ability to level up the provided supportive care and to predict the risk o...

Perceptions of COVID-19 among communities of Conakry (Guinea): a qualitative study exploring the context of the ANRS COV33 Coverage-Africa therapeutic trial

Archive ouverte | Doucet, Marie-Hélène | CCSD

International audience. Objectives To explore communities’ perceptions about COVID-19 in the context of the ANRS COV33 Coverage-Africa clinical trial evaluating the efficacy of treatments in preventing clinical wors...

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

Archive ouverte | Wiedemann, Aurélie | CCSD

International audience. Recent Ebola outbreaks underscore the importance of continuous prevention and disease control efforts. Authorized vaccines include Merck’s Ervebo (rVSV-ZEBOV) and Johnson & Johnson’s two-...

Chargement des enrichissements...